HomeEWTX • NASDAQ
add
Edgewise Therapeutics Inc
Previous close
$14.67
Day range
$14.20 - $14.75
Year range
$10.60 - $38.12
Market cap
1.50B USD
Avg Volume
766.36K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 42.61M | 11.82% |
Net income | -36.12M | -14.66% |
Net profit margin | — | — |
Earnings per share | -0.34 | 0.00% |
EBITDA | -42.09M | -11.85% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 593.99M | 16.07% |
Total assets | 613.33M | 15.36% |
Total liabilities | 24.26M | 14.59% |
Total equity | 589.07M | — |
Shares outstanding | 105.35M | — |
Price to book | 2.62 | — |
Return on assets | -19.95% | — |
Return on capital | -20.73% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -36.12M | -14.66% |
Cash from operations | -32.58M | -24.84% |
Cash from investing | -162.17M | -533.97% |
Cash from financing | 188.23M | 9,542.98% |
Net change in cash | -6.52M | -149.29% |
Free cash flow | -21.08M | -43.08% |
About
Founded
2017
Headquarters
Website
Employees
126
